Fabio
4.1 KiB
4.1 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | AN ACT relating to use of experimental treatments for terminal illnesses. Create new sections of KRS Chapter 217 to define terms; permit eligible patients to use investigational drugs, biological products, or devices for a terminal illness; establish the conditions for use of such experimental treatments; prohibit sanctions of health care providers; clarify the duties of health care insurers regarding experimental treatments; prohibit certain actions by state officials. | AN ACT relating to use of experimental treatments for terminal illnesses. Create new sections of KRS Chapter 217 to define terms; permit eligible patients to use investigational drugs, biological products, or devices for a terminal illness; establish the conditions for use of such experimental treatments; prohibit sanctions of health care providers; clarify the duties of health care insurers regarding experimental treatments; prohibit certain actions by state officials. | us/states/ky | Kentucky General Assembly | 2017RS | SB 21 | Kentucky SB 21 (2017RS) |
|
enacted | 3 | 18 | 0 | 2017-01-03 | 2017-03-21 | openstates | ocd-bill/452214de-bed3-4de7-9cdb-fb1d00adee7f | http://www.lrc.ky.gov/record/17RS/SB21.htm | 1f02821821c98b2664fffd12175707fe1816e228e13647a25a1824bd29953ecc | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Kentucky SB 21 (2017RS) — AN ACT relating to use of experimental treatments for terminal illnesses. Create new sections of KRS Chapter 217 to define terms; permit eligible patients to use investigational drugs, biological products, or devices for a terminal illness; establish the conditions for use of such experimental treatments; prohibit sanctions of health care providers; clarify the duties of health care insurers regarding experimental treatments; prohibit certain actions by state officials.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- Most Recent Version (committee substitute) — source
- SB 21 (As Introduced) (committee substitute) — source
- SCS1 (committee substitute) — source
Timeline
The legislative action history — every referral, reading, and vote.
- 2017-01-03 Introduced in Senate
introduction - 2017-01-07 To Health & Welfare (S)
referral-committee - 2017-02-15 Reported favorably, 1st reading, to Calendar with Committee Substitute
reading-1 - 2017-02-16 2nd reading, to Rules
reading-2 - 2017-02-17 Posted for passage in the Regular Orders of the Day for Tuesday, February 21, 2017
- 2017-02-21 3rd reading, passed 38-0 with Committee Substitute
reading-3, passage - 2017-02-22 Received in House
- 2017-02-27 To Health and Family Services (H)
referral-committee - 2017-03-01 Posted in committee
- 2017-03-02 Reported favorably, 1st reading, to Calendar
reading-1 - 2017-03-03 2nd reading, to Rules
reading-2 - 2017-03-06 Posted for passage in the Regular Orders of the Day for Tuesday, March 7, 2017
- 2017-03-14 3rd reading, passed 87-7
reading-3, passage - 2017-03-14 Received in Senate
- 2017-03-14 Enrolled, signed by President of the Senate
- 2017-03-14 Enrolled, signed by Speaker of the House
- 2017-03-14 Delivered to Governor
- 2017-03-21 Signed by Governor (Acts, ch. 65)
executive-signature
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/452214de-bed3-4de7-9cdb-fb1d00adee7f. Confidence: reported (aggregated from official Kentucky legislature records).